Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

CUSIP: 12233L107

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Total 13F shares
23,578,976
Total 13F value
$634,746,122
Holder snapshot 6 signals
Share change
+3,067,145
SEC-reported price per share
$26.92
Number of holders
51
Value change
+$86,851,459
Number of buys
26
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,036,176

Security key

12233L107

Report period

Q1 2021

Institutions

51

Top holders

10

BNR full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2021 Previous quarter: Q4 2020 Burning Rock Biotech Ltd SEC filings Burning Rock Biotech Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 46% Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 46%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
ORBIMED ADVISORS LLC 46%
Casdin Capital, LLC 21%
JENNISON ASSOCIATES LLC 20%
MATTHEWS INTERNATIONAL CAPITAL MA... 19%
BAILLIE GIFFORD & CO 17%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
46%
$96,135,000
4,161,675 shares
 — 31 Dec 2020
Casdin Capital, LLC
13F
Company
13F
21%
$44,402,000
1,922,150 shares
 — 31 Dec 2020
JENNISON ASSOCIATES LLC
13F
Company
13F
20%
$42,130,000
1,823,823 shares
 — 31 Dec 2020
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC
13F
Company
13F
19%
$38,944,000
1,685,908 shares
 — 31 Dec 2020
BAILLIE GIFFORD & CO
13F
Company
13F
17%
$36,442,000
1,577,557 shares
 — 31 Dec 2020
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
13F
14%
$28,598,000
1,238,000 shares
 — 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
51
Shares
23,578,976
Rows available
51
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
57
Q1 2021 holders
51
Holder diff
-6
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .